Petition files against Chandrababu Naidu for voilating lockdown rules
26-05-2020 Tue 09:43
AMARAVATI: A petition has been filed against former Andhra Pradesh chief minister, Telugu Desam Party national president Chandrababu Naidu for allegedly violating the lockdown rules as soon as he entered into Andhra Pradesh. According to the sources, YSRCP MLC V Gopal Reddy filed a petition in High Court citing that the Chandrababu Naidu violated the lockdown rules during the pandemic.
It is mentioned in the petition that even there is no permission for rallies and campaigns in the state, thousands of TDP activists and workers thronged to welcome the TDP chief Chandrababu at Nadigama, Garikapadu, Kanchikacherla, Gollapudi, Ibrahimpatnam and Vijayawada. They alleged that the TDP cadre failed to wear face masks and physical distance. Click the video for more information.
More Latest Video News
7 AM Telugu News: 14th May 2021
7 AM Telugu News Headlines Dated 14th May 2021:-* Telangana minister K Taraka Rama Rao said that he will hold talks with CM KCR to consider including Covid treatment under Arogyasri.* Telangana..
Black fungus cases detected in Nirmal, one die
Nirmal: Mucormycosis also known as black fungus cases increasing in Telangana and another five cases detected in Bhainsa, Nirmal district. According to the reports, five new black fungus cases reported among post-Covid patients and..
9 PM Telugu News: 13th May 2021
9 PM Telugu News Headlines Dated May 13th, 2021:-* According to the center, 216 crore corona vaccine doses to be available from August to December.* The center said for the manufacturing of..
Good news for Google Pay users
It is good news for Google Pay users to send money to people in India and Singapore in an effortless manner. It is good news for Indian users as well because many Indian people..
mRNA: Another COVID vaccine soon to India..!
A company named Lupin has been willing to take partners to bring mRNA Covid-19 vaccines to India. According to the reports, Lupin is likely to work with other vaccine makers. Reports suggest that Pfizer..